Transverse Myelitis

Transverse myelitis (TM) is a rare inflammatory neurological disorder characterized by focal inflammation of one or more segments of the spinal cord. This inflammation damages myelin, the protective covering of nerve fibers, interrupting signals sent between the spinal cord and the rest of the body. TM can present acutely or subacutely, causing motor, sensory, and autonomic dysfunction below the level of the lesion.

• Idiopathic: No identifiable cause (approx. 30–60% of cases).

• Systemic Autoimmune Disorders: Systemic Lupus Erythematosus (SLE), Sjögren's syndrome, sarcoidosis, and Behcet's disease.
• Acquired Demyelinating Diseases: Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD), and Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD).
• Vaccine-associated: Rare post-vaccination immune-mediated responses.

The core mechanism involves an autoimmune-mediated inflammatory cascade localized to the spinal cord. Molecular mimicry after an infection or a direct autoimmune attack triggers T-cell and macrophage infiltration across the blood-brain barrier. These inflammatory cells release proinflammatory cytokines, causing oligodendrocyte apoptosis, demyelination, and subsequent axonal damage within cross-sectional (transverse) segments of the spinal cord.

• Incidence: Approximately 1 to 4 new cases per million people annually.
• Age Distribution: Bimodal distribution, peaking between ages 10–19 and 30–3

• Gender: No significant gender predisposition, except when secondary to underlying autoimmune diseases (which skew female).

• Recent viral or bacterial respiratory or gastrointestinal infection.
• Pre-existing autoimmune disorders (SLE, Sjögren's).
• Family or personal history of demyelinating diseases (MS, NMOSD).

• Vitals: Bradycardia and hypertension if autonomic dysreflexia is active.
• Inspection: Gait abnormalities or inability to stand.

• Motor: Flaccid weakness in the acute phase (spinal shock), progressing to spastic weakness, hyperreflexia, and positive Babinski signs.
• Sphincter: Reduced anal sphincter tone.

• A. Clinical Assessment: Comprehensive neurological exam to establish a spinal sensory level.
• B. Laboratory Testing: Blood tests for autoantibodies; CSF analysis to confirm inflammation.
• C. Imaging Studies: Contrast-enhanced spinal MRI.
• D. Functional Tests: Somatosensory evoked potentials (SSEP).
• E. Biopsy Findings: Rarely performed; shows perivascular lymphocytic infiltration and demyelination.
• F. Genetic Testing: Not indicated.
• G. Differential Diagnosis: Spinal cord compression, spinal vascular accidents, vitamin B12 deficiency.

Lumbar Puncture (CSF Analysis)
Type: Cerebrospinal Fluid (CSF) Test
Purpose: To assess for CNS inflammation and rule out active infection.
Expected Findings: Elevated protein (100–250 mg/dL), moderate lymphocytic pleocytosis, and elevated IgG index.
Interpretation: Confirms an active inflammatory process; negative PCR rules out direct viral infection. Aquaporin-4 Antibody (AQP4-IgG)
Type: Blood Test
Purpose: To differentiate idiopathic TM from NMOSD.
Expected Findings: Negative in idiopathic TM; Positive in NMOSD-related myelitis.
Interpretation: High specificity; positive result guides long-term immunosuppressive management.

Spinal MRI (with and without Gadolinium): Purpose: To confirm myelitis and rule out compressive lesions.

• Typical Findings: T2-hyperintense signal spanning 1 to 3 vertebral segments (idiopathic) or >3 segments (Longitudinally Extensive Transverse Myelitis - LETM), with patch/variable gadolinium enhancement.


• Clinical Importance: Gold standard; excludes surgical emergencies like epidural abscess or cord compression.

• Spinal Cord Compression (e.g., herniated disc, tumor): Distinguished by focal mechanical obstruction on MRI.
• Anterior Spinal Artery Infarction: Abrupt onset (seconds to minutes), spares dorsal columns (proprioception/vibration preserved).
• Multiple Sclerosis (MS): Typically presents with partial myelitis (spanning <2 segments and affecting only a portion of the cross-section).

• Chronic neuropathic pain.
• Spasticity and joint contractures.
• Recurrent urinary tract infections (UTIs) due to neurogenic bladder.
• Autonomic dysreflexia.
• Deep vein thrombosis (DVT) / Pulmonary embolism.

• Recovery Profile: Roughly one-third of patients experience complete or near-complete recovery, one-third retain moderate disability (spastic gait, urinary urgency), and one-third remain severely disabled or non-ambulatory.
• Timeline: Recovery typically begins within 2 to 12 weeks and can continue for up to 2 years.

• No primary prevention exists for idiopathic cases.
• Secondary prevention involves long-term immunosuppression for patients with underlying MS or NMOSD.

The following homeopathic remedies have been historically indicated for symptoms associated with Transverse Myelitis. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Transverse Myelitis.